Table of Contents 1 Liraglutide Drugs Market Overview 1.1 Product Overview and Scope of Liraglutide Drugs 1.2 Liraglutide Drugs Segment by Type 1.2.1 Global Liraglutide Drugs Sales Growth Rate Comparison by Type (2021-2026) 1.2.2 Victoza 1.2.3 Saxenda 1.3 Liraglutide Drugs Segment by Application 1.3.1 Liraglutide Drugs Sales Comparison by Application: 2020 VS 2026 1.3.2 Type 2 Diabetes 1.3.3 Obesity 1.4 Global Liraglutide Drugs Market Size Estimates and Forecasts 1.4.1 Global Liraglutide Drugs Revenue 2015-2026 1.4.2 Global Liraglutide Drugs Sales 2015-2026 1.4.3 Liraglutide Drugs Market Size by Region: 2020 Versus 2026 2 Global Liraglutide Drugs Market Competition by Manufacturers 2.1 Global Liraglutide Drugs Sales Market Share by Manufacturers (2015-2020) 2.2 Global Liraglutide Drugs Revenue Share by Manufacturers (2015-2020) 2.3 Global Liraglutide Drugs Average Price by Manufacturers (2015-2020) 2.4 Manufacturers Liraglutide Drugs Manufacturing Sites, Area Served, Product Type 2.5 Liraglutide Drugs Market Competitive Situation and Trends 2.5.1 Liraglutide Drugs Market Concentration Rate 2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue 2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 2.7 Primary Interviews with Key Liraglutide Drugs Players (Opinion Leaders) 3 Liraglutide Drugs Retrospective Market Scenario by Region 3.1 Global Liraglutide Drugs Retrospective Market Scenario in Sales by Region: 2015-2020 3.2 Global Liraglutide Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020 3.3 North America Liraglutide Drugs Market Facts & Figures by Country 3.3.1 North America Liraglutide Drugs Sales by Country 3.3.2 North America Liraglutide Drugs Sales by Country 3.3.3 U.S. 3.3.4 Canada 3.4 Europe Liraglutide Drugs Market Facts & Figures by Country 3.4.1 Europe Liraglutide Drugs Sales by Country 3.4.2 Europe Liraglutide Drugs Sales by Country 3.4.3 Germany 3.4.4 France 3.4.5 U.K. 3.4.6 Italy 3.4.7 Russia 3.5 Asia Pacific Liraglutide Drugs Market Facts & Figures by Region 3.5.1 Asia Pacific Liraglutide Drugs Sales by Region 3.5.2 Asia Pacific Liraglutide Drugs Sales by Region 3.5.3 China 3.5.4 Japan 3.5.5 South Korea 3.5.6 India 3.5.7 Australia 3.5.8 Taiwan 3.5.9 Indonesia 3.5.10 Thailand 3.5.11 Malaysia 3.5.12 Philippines 3.5.13 Vietnam 3.6 Latin America Liraglutide Drugs Market Facts & Figures by Country 3.6.1 Latin America Liraglutide Drugs Sales by Country 3.6.2 Latin America Liraglutide Drugs Sales by Country 3.6.3 Mexico 3.6.3 Brazil 3.6.3 Argentina 3.7 Middle East and Africa Liraglutide Drugs Market Facts & Figures by Country 3.7.1 Middle East and Africa Liraglutide Drugs Sales by Country 3.7.2 Middle East and Africa Liraglutide Drugs Sales by Country 3.7.3 Turkey 3.7.4 Saudi Arabia 3.7.5 U.A.E 4 Global Liraglutide Drugs Historic Market Analysis by Type 4.1 Global Liraglutide Drugs Sales Market Share by Type (2015-2020) 4.2 Global Liraglutide Drugs Revenue Market Share by Type (2015-2020) 4.3 Global Liraglutide Drugs Price Market Share by Type (2015-2020) 4.4 Global Liraglutide Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End 5 Global Liraglutide Drugs Historic Market Analysis by Application 5.1 Global Liraglutide Drugs Sales Market Share by Application (2015-2020) 5.2 Global Liraglutide Drugs Revenue Market Share by Application (2015-2020) 5.3 Global Liraglutide Drugs Price by Application (2015-2020) 6 Company Profiles and Key Figures in Liraglutide Drugs Business 6.1 Novo Nordisk 6.1.1 Corporation Information 6.1.2 Novo Nordisk Description, Business Overview and Total Revenue 6.1.3 Novo Nordisk Liraglutide Drugs Sales, Revenue and Gross Margin (2015-2020) 6.1.4 Novo Nordisk Products Offered 6.1.5 Novo Nordisk Recent Development 6.2 Mylan 6.2.1 Mylan Liraglutide Drugs Production Sites and Area Served 6.2.2 Mylan Description, Business Overview and Total Revenue 6.2.3 Mylan Liraglutide Drugs Sales, Revenue and Gross Margin (2015-2020) 6.2.4 Mylan Products Offered 6.2.5 Mylan Recent Development 7 Liraglutide Drugs Manufacturing Cost Analysis 7.1 Liraglutide Drugs Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Raw Materials Price Trend 7.1.3 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of Liraglutide Drugs 7.4 Liraglutide Drugs Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 Liraglutide Drugs Distributors List 8.3 Liraglutide Drugs Customers 9 Market Dynamics 9.1 Market Trends 9.2 Opportunities and Drivers 9.3 Challenges 9.4 Porter's Five Forces Analysis 10 Global Market Forecast 10.1 Global Liraglutide Drugs Market Estimates and Projections by Type 10.1.1 Global Forecasted Sales of Liraglutide Drugs by Type (2021-2026) 10.1.2 Global Forecasted Revenue of Liraglutide Drugs by Type (2021-2026) 10.2 Liraglutide Drugs Market Estimates and Projections by Application 10.2.1 Global Forecasted Sales of Liraglutide Drugs by Application (2021-2026) 10.2.2 Global Forecasted Revenue of Liraglutide Drugs by Application (2021-2026) 10.3 Liraglutide Drugs Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of Liraglutide Drugs by Region (2021-2026) 10.3.2 Global Forecasted Revenue of Liraglutide Drugs by Region (2021-2026) 10.4 North America Liraglutide Drugs Estimates and Projections (2021-2026) 10.5 Europe Liraglutide Drugs Estimates and Projections (2021-2026) 10.6 Asia Pacific Liraglutide Drugs Estimates and Projections (2021-2026) 10.7 Latin America Liraglutide Drugs Estimates and Projections (2021-2026) 10.8 Middle East and Africa Liraglutide Drugs Estimates and Projections (2021-2026) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer

List of Tables Table 1. Global Liraglutide Drugs Sales (K Units) Growth Rate Comparison by Type (2015-2026) Table 2. Global Liraglutide Drugs Sales (K Units) Comparison by Application: 2020 VS 2026 Table 3. Global Liraglutide Drugs Market Size by Type (K Units) (US$ Million) (2020 VS 2026) Table 4. Global Key Liraglutide Drugs Manufacturers Covered in This Study Table 5. Global Liraglutide Drugs Sales (K Units) by Manufacturers (2015-2020) Table 6. Global Liraglutide Drugs Sales Share by Manufacturers (2015-2020) Table 7. Global Liraglutide Drugs Revenue (Million USD) by Manufacturers (2015-2020) Table 8. Global Liraglutide Drugs Revenue Share by Manufacturers (2015-2020) Table 9. Global Market Liraglutide Drugs Average Price (USD/Unit) of Key Manufacturers (2015-2020) Table 10. Manufacturers Liraglutide Drugs Sales Sites and Area Served Table 11. Manufacturers Liraglutide Drugs Product Types Table 12. Global Liraglutide Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Liraglutide Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Liraglutide Drugs as of 2019) Table 14.Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Main Points Interviewed from Key Liraglutide Drugs Players Table 16. Global Liraglutide Drugs Sales (K Units) by Region (2015-2020) Table 17. Global Liraglutide Drugs Sales Market Share by Region (2015-2020) Table 18. Global Liraglutide Drugs Revenue (Million US$) by Region (2015-2020) Table 19. Global Liraglutide Drugs Revenue Market Share by Region (2015-2020) Table 20. North America Liraglutide Drugs Sales by Country (2015-2020) (K Units) Table 21. North America Liraglutide Drugs Sales Market Share by Country (2015-2020) Table 22. North America Liraglutide Drugs Revenue by Country (2015-2020) (US$ Million) Table 23. North America Liraglutide Drugs Revenue Market Share by Country (2015-2020) Table 24. Europe Liraglutide Drugs Sales by Country (2015-2020) (K Units) Table 25. Europe Liraglutide Drugs Sales Market Share by Country (2015-2020) Table 26. Europe Liraglutide Drugs Revenue by Country (2015-2020) (US$ Million) Table 27. Europe Liraglutide Drugs Revenue Market Share by Country (2015-2020) Table 28. Asia Pacific Liraglutide Drugs Sales by Region (2015-2020) (K Units) Table 29. Asia Pacific Liraglutide Drugs Sales Market Share by Region (2015-2020) Table 30. Asia Pacific Liraglutide Drugs Revenue by Region (2015-2020) (US$ Million) Table 31. Asia Pacific Liraglutide Drugs Revenue Market Share by Region (2015-2020) Table 32. Latin America Liraglutide Drugs Sales by Country (2015-2020) (K Units) Table 33. Latin America Liraglutide Drugs Sales Market Share by Country (2015-2020) Table 34. Latin America Liraglutide Drugs Revenue by Country (2015-2020) (US$ Million) Table 35. Latin America Liraglutide Drugs Revenue Market Share by Country (2015-2020) Table 36. Middle East and Africa Liraglutide Drugs Sales by Country (2015-2020) (K Units) Table 37. Middle East and Africa Liraglutide Drugs Sales Market Share by Country (2015-2020) Table 38. Middle East and Africa Liraglutide Drugs Revenue by Country (2015-2020) (US$ Million) Table 39. Middle East and Africa Liraglutide Drugs Revenue Market Share by Country (2015-2020) Table 40. Global Liraglutide Drugs Sales (K Units) by Type (2015-2020) Table 41. Global Liraglutide Drugs Sales Share by Type (2015-2020) Table 42. Global Liraglutide Drugs Revenue (Million US$) by Type (2015-2020) Table 43. Global Liraglutide Drugs Revenue Share by Type (2015-2020) Table 44. Global Liraglutide Drugs Price (USD/Unit) by Type (2015-2020) Table 45. Global Liraglutide Drugs Sales (K Units) by Application (2015-2020) Table 46. Global Liraglutide Drugs Sales Market Share by Application (2015-2020) Table 47. Global Liraglutide Drugs Sales Growth Rate by Application (2015-2020) Table 48. Novo Nordisk Liraglutide Drugs Corporation Information Table 49. Novo Nordisk Description and Business Overview Table 50. Novo Nordisk Liraglutide Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 51. Novo Nordisk Main Product Table 52. Novo Nordisk Recent Development Table 53. Mylan Liraglutide Drugs Corporation Information Table 54. Mylan Corporation Information Table 55. Mylan Liraglutide Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 56. Mylan Main Product Table 57. Mylan Recent Development Table 58. Sales Base and Market Concentration Rate of Raw Material Table 59. Key Suppliers of Raw Materials Table 60. Liraglutide Drugs Distributors List Table 61. Liraglutide Drugs Customers List Table 62. Market Key Trends Table 63. Key Opportunities and Drivers: Impact Analysis (2021-2026) Table 64. Key Challenges Table 65. Global Liraglutide Drugs Sales (K Units) Forecast by Type (2021-2026) Table 66. Global Liraglutide Drugs Sales Market Share Forecast by Type (2021-2026) Table 67. Global Liraglutide Drugs Revenue (Million US$) Forecast by Type (2021-2026) Table 68. Global Liraglutide Drugs Revenue (Million US$) Market Share Forecast by Type (2021-2026) Table 69. Global Liraglutide Drugs Sales (K Units) Forecast by Application (2021-2026) Table 70. Global Liraglutide Drugs Revenue (Million US$) Forecast by Application (2021-2026) Table 71. Global Liraglutide Drugs Sales (K Units) Forecast by Region (2021-2026) Table 72. Global Liraglutide Drugs Sales Market Share Forecast by Region (2021-2026) Table 73. Global Liraglutide Drugs Revenue Forecast by Region (2021-2026) (US$ Million) Table 74. Global Liraglutide Drugs Revenue Market Share Forecast by Region (2021-2026) Table 75. Research Programs/Design for This Report Table 76. Key Data Information from Secondary Sources Table 77. Key Data Information from Primary Sources List of Figures Figure 1. Picture of Liraglutide Drugs Figure 2. Global Liraglutide Drugs Sales Market Share by Type: 2020 VS 2026 Figure 3. Victoza Product Picture Figure 4. Saxenda Product Picture Figure 5. Global Liraglutide Drugs Consumption Market Share by Application: 2020 VS 2026 Figure 6. Type 2 Diabetes Figure 7. Obesity Figure 8. Global Liraglutide Drugs Market Size 2015-2026 (US$ Million) Figure 9. Global Liraglutide Drugs Sales Capacity (K Units) (2015-2026) Figure 10. Global Liraglutide Drugs Market Size Market Share by Region: 2020 Versus 2026 Figure 11. Liraglutide Drugs Sales Share by Manufacturers in 2020 Figure 12. Global Liraglutide Drugs Revenue Share by Manufacturers in 2019 Figure 13. The Global 5 and 10 Largest Players: Market Share by Liraglutide Drugs Revenue in 2019 Figure 14. Liraglutide Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019 Figure 15. Global Liraglutide Drugs Sales Market Share by Region (2015-2020) Figure 16. Global Liraglutide Drugs Sales Market Share by Region in 2019 Figure 17. Global Liraglutide Drugs Revenue Market Share by Region (2015-2020) Figure 18. Global Liraglutide Drugs Revenue Market Share by Region in 2019 Figure 19. North America Liraglutide Drugs Sales Market Share by Country in 2019 Figure 20. North America Liraglutide Drugs Revenue Market Share by Country in 2019 Figure 21. U.S. Liraglutide Drugs Sales Growth Rate (2015-2020) (K Units) Figure 22. U.S. Liraglutide Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 23. Canada Liraglutide Drugs Sales Growth Rate (2015-2020) (K Units) Figure 24. Canada Liraglutide Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 25. Europe Liraglutide Drugs Sales Market Share by Country in 2019 Figure 26. Europe Liraglutide Drugs Revenue Market Share by Country in 2019 Figure 27. Germany Liraglutide Drugs Sales Growth Rate (2015-2020) (K Units) Figure 28. Germany Liraglutide Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 29. France Liraglutide Drugs Sales Growth Rate (2015-2020) (K Units) Figure 30. France Liraglutide Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 31. U.K. Liraglutide Drugs Sales Growth Rate (2015-2020) (K Units) Figure 32. U.K. Liraglutide Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 33. Italy Liraglutide Drugs Sales Growth Rate (2015-2020) (K Units) Figure 34. Italy Liraglutide Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 35. Russia Liraglutide Drugs Sales Growth Rate (2015-2020) (K Units) Figure 36. Russia Liraglutide Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 37. Asia Pacific Liraglutide Drugs Sales Market Share by Region in 2019 Figure 38. Asia Pacific Liraglutide Drugs Revenue Market Share by Region in 2019 Figure 39. China Liraglutide Drugs Sales Growth Rate (2015-2020) (K Units) Figure 40. China Liraglutide Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 41. Japan Liraglutide Drugs Sales Growth Rate (2015-2020) (K Units) Figure 42. Japan Liraglutide Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 43. South Korea Liraglutide Drugs Sales Growth Rate (2015-2020) (K Units) Figure 44. South Korea Liraglutide Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 45. India Liraglutide Drugs Sales Growth Rate (2015-2020) (K Units) Figure 46. India Liraglutide Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 47. Australia Liraglutide Drugs Sales Growth Rate (2015-2020) (K Units) Figure 48. Australia Liraglutide Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 49. Taiwan Liraglutide Drugs Sales Growth Rate (2015-2020) (K Units) Figure 50. Taiwan Liraglutide Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 51. Indonesia Liraglutide Drugs Sales Growth Rate (2015-2020) (K Units) Figure 52. Indonesia Liraglutide Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 53. Thailand Liraglutide Drugs Sales Growth Rate (2015-2020) (K Units) Figure 54. Thailand Liraglutide Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 55. Malaysia Liraglutide Drugs Sales Growth Rate (2015-2020) (K Units) Figure 56. Malaysia Liraglutide Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 57. Philippines Liraglutide Drugs Sales Growth Rate (2015-2020) (K Units) Figure 58. Philippines Liraglutide Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 59. Vietnam Liraglutide Drugs Sales Growth Rate (2015-2020) (K Units) Figure 60. Vietnam Liraglutide Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 61. Latin America Liraglutide Drugs Sales Market Share by Country in 2019 Figure 62. Latin America Liraglutide Drugs Revenue Market Share by Country in 2019 Figure 63. Mexico Liraglutide Drugs Sales Growth Rate (2015-2020) (K Units) Figure 64. Mexico Liraglutide Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 65. Brazil Liraglutide Drugs Sales Growth Rate (2015-2020) (K Units) Figure 66. Brazil Liraglutide Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 67. Argentina Liraglutide Drugs Sales Growth Rate (2015-2020) (K Units) Figure 68. Argentina Liraglutide Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 69. Middle East and Africa Liraglutide Drugs Sales Market Share by Country in 2019 Figure 70. Middle East and Africa Liraglutide Drugs Revenue Market Share by Country in 2019 Figure 71. Turkey Liraglutide Drugs Sales Growth Rate (2015-2020) (K Units) Figure 72. Turkey Liraglutide Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 73. Saudi Arabia Liraglutide Drugs Sales Growth Rate (2015-2020) (K Units) Figure 74. Saudi Arabia Liraglutide Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 75. U.A.E Liraglutide Drugs Sales Growth Rate (2015-2020) (K Units) Figure 76. U.A.E Liraglutide Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 77. Sales Market Share of Liraglutide Drugs by Type (2015-2020) Figure 78. Sales Market Share of Liraglutide Drugs by Type in 2019 Figure 79. Revenue Share of Liraglutide Drugs by Type (2015-2020) Figure 80. Revenue Market Share of Liraglutide Drugs by Type in 2019 Figure 81. Global Liraglutide Drugs Sales Growth by Type (2015-2020) (K Units) Figure 82. Global Liraglutide Drugs Sales Market Share by Application (2015-2020) Figure 83. Global Liraglutide Drugs Sales Market Share by Application in 2019 Figure 84. Global Revenue Share of Liraglutide Drugs by Application (2015-2020) Figure 85. Global Revenue Share of Liraglutide Drugs by Application in 2020 Figure 86. Novo Nordisk Total Revenue (US$ Million): 2019 Compared with 2018 Figure 87. Mylan Total Revenue (US$ Million): 2019 Compared with 2018 Figure 88. Price Trend of Key Raw Materials Figure 89. Manufacturing Cost Structure of Liraglutide Drugs Figure 90. Manufacturing Process Analysis of Liraglutide Drugs Figure 91. Liraglutide Drugs Industrial Chain Analysis Figure 92. Channels of Distribution Figure 93. Distributors Profiles Figure 94. Porter's Five Forces Analysis Figure 95. North America Liraglutide Drugs Sales (K Units) and Growth Rate Forecast (2021-2026) Figure 96. North America Liraglutide Drugs Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 97. Europe Liraglutide Drugs Sales (K Units) and Growth Rate Forecast (2021-2026) Figure 98. Europe Liraglutide Drugs Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 99. Latin America Liraglutide Drugs Sales (K Units) and Growth Rate Forecast (2021-2026) Figure 100. Latin America Liraglutide Drugs Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 101. Middle East and Africa Liraglutide Drugs Sales (K Units) and Growth Rate Forecast (2021-2026) Figure 102. Middle East and Africa Liraglutide Drugs Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 103. Asia Pacific Liraglutide Drugs Sales (K Units) and Growth Rate Forecast (2021-2026) Figure 104. Asia Pacific Liraglutide Drugs Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 105. Bottom-up and Top-down Approaches for This Report Figure 106. Data Triangulation Figure 107. Key Executives Interviewed

Novo Nordisk Mylan